Victor I Reus, University of California, San Francisco, CA, USA
Published online: May 2005
DOI: 10.1038/npg.els.0003850
Moods are fundamental emotional states that govern internal experience and adaptive survival. Clinical disorders of mood are prevalent and emerge out of a confluence of genetic, developmental and environmental risk factors to adversely affect morbidity, mortality and function. Although the understanding of causation remains obscure, current treatment options are numerous and highly effective in the majority of cases.
Keywords: mood; depression; mania; bipolar; antidepressant
| References | |
| Bauer M, Whybrow PC, Angst Jet al.(2002a) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, Part 1: Acute and continuation treatment of major depressive disorder. World Journal of Biological Psychiatry 3: 5–43. | |
| Bauer M, Whybrow PC, Angst J et al. (2002b) World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders, Part 2: Maintenance treatment of major depressive disorder and treatment of chronic depressive disorders and subthreshold depressions. World Journal of Biological Psychiatry 3: 69–86. | |
| Belmaker RH (2004) Bipolar disorder. New England Journal of Medicine 5: 476–486. | |
| book Bogousslavsky J and Cummings JL (eds) (2000) Behavior and Mood Disorders in Focal Brain Lesions. Cambridge: Cambridge University Press. | |
| Caspi A, Sugden K, Moffitt TE et al. (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301: 386–389. | |
| Charney DS and Manji HK (2004) Life stress, genes, and depression: multiple pathways lead to increased risk and new opportunities for intervention. Science's STKE 225: re5: [DOI: 10.1126/stke.2252004re5]. | |
| Coyle JT and Duman RS (2003) Finding the intracellular signaling pathways affected by mood disorder treatments. Neuron 38: 157–160. | |
| Duman RS (2004) Role of neurotrophic factors in the etiology and treatment of mood disorder. Neuromolecular Medicine 1: 11–25. | |
| Gilbert P and Allan S (1998) The role of defeat and entrapment (arrested flight) in depression: an exploration of an evolutionary view. Psychological Medicine 28: 585–598. | |
| Keck PE Jr, Nelson EB and McElroy SL (2003) Advances in the pharmacologic treatment of bipolar depression. Biological Psychiatry 53: 671–679. | |
| Kessler RC, Berglund P, Demler O et al. (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCSR). JAMA 289: 3095–3105. | |
| Kleinman A (2004) Culture and depression. New England Journal of Medicine 10: 951–953. | |
| Lett HS, Blumenthal JA, Babyak MA et al. (2004) Depression as a risk factor for coronary artery disease: evidence, mechanism and treatment. Psychosomatic Medicine 3: 305–315. | |
| Manji HK, Quiroz JA, Sporn J et al. (2003) Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biological Psychiatry 53: 707–742. | |
| Mathews CA and Reus VI (2003) Genetic linkage in bipolar disorder. CNS Spectrums 12: 891–904. | |
| Nestler EJ, Barrot M, DiLeone RJ et al. (2002) Neurobiology of depression. Neuron 34: 13–25. | |
| O'Brien SM, Scott LV and Dinan TG (2004) Cytokines: abnormalities in major depression and implications for pharmacological treatment. Human Psychopharmacology 6: 397–403. | |
| Pampallona S, Bollini P, Tibaldi G et al. (2004) Combined pharmacotherapy and psychological treatment for depression: a systematic review. Archives of General Psychiatry 7: 714–719. | |
| Schloss P and Henn FA (2004) New insights into the mechanisms of antidepressant therapy. Pharmacology & Therapeutics 1: 47–60. | |
| Sheline YI, Mittler BL and Mintun MA (2002) The hippocampus and depression. European Psychiatry 3: 300–305. | |
| Stewart WF, Ricci JA, Chee E et al. (2003) Cost of lost productive work time among US workers with depression. JAMA 289: 3135–3144. | |
| Sulser F (2002) The role of CREB and other transcription factors in the pharmacotherapy and etiology of depression. Annals of Medicine 34: 348–356. | |
| Further Reading | |
| American Psychiatric Association, Practice Guidelines Work Group and Steering Committee (2000) Practice guideline for the treatment of patients with major depressive disorder (revision). American Journal of Psychiatry 157: 1–45. | |
| Duman RS (2004) Depression: a case of neuronal life and death? Biological Psychiatry 3: 140–145. | |
| Farvolden P, Kennedy SH and Lam RW (2003) Recent developments in the psychobiology and pharmacotherapy of depression: optimizing existing treatments and novel approaches for the future. Expert Opinion on Investigational Drugs 12: 65–86. | |
| Harmer CJ, Hill SA, Taylor MJ et al. (2003) Toward a neuropsychological theory of antidepressant drug action: increase in positive emotional bias after potentiation of norepinephrine activity. American Journal of Psychiatry 160: 990–992. | |
| Jang KL, Livesley WJ, Taylor S et al. (2003) Heritability of individual depressive symptoms. Journal of Affective Disorders 76: 1–9. | |
| Kendler KS, Gardner CO and Prescott CA (2002) Toward a comprehensive developmental model for major depression in women. American Journal of Psychiatry 159: 1133–1145. | |
| Malberg JE (2004) Implications of adult hippocampal neurogenesis in anti-depressant action. Journal of Psychiatry & Neuroscience 3: 196–205. | |
| Mayberg HS (2003) Modulating dysfunctional limbic-cortical circuits in depression: Towards development of brain-based algorithms for diagnosis and optimized treatment. British Medical Bulletin 65: 193–207. | |
| Nesse RM (2000) Is depression an adaptation? Archives of General Psychiatry 57: 14–29. | |
| Ormel J, Oldehinkel AJ and Brilman EI (2001) The interplay and etiological continuity of neuroticism, difficulties, and life events in the etiology of major and subsyndromal, first and recurrent depressive episodes in later life. American Journal of Psychiatry 158: 885–891. | |
| Unutzer J, Patrick DL, Marmon T et al. (2002) Severe depression linked to increased risk of death. American Journal of Geriatric Psychiatry 10: 521–530. | |
| Whooley MA and Simon GE (2000) Managing depression in medical outpatients. New England Journal of Medicine 346: 1942–1949. | |
| Williams RSB, Cheng L, Mudge AW et al. (2002) A common mechanism of action for three mood-stabilizing drugs. Nature 417: 292–295. | |
| Wolkowitz OM, Epel ES and Reus VI (2001) Stress hormone-related psychopathology: pathophysiological and treatment implications. World Journal of Biological Psychiatry 2: 115–143. | |
Copyright © 2000-2013 by John Wiley & Sons, Inc., or related companies. All rights reserved.
